ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters

Objective: To examine retrospectively the changes in ECG parameters over time and their correlation with other quantitative right ventricular (RV) function parameters in patients with chronic RV pressure overload caused by congenital heart disease. Methods: 48 patients with chronic RV pressure overload caused by the following congenital heart diseases were studied: nine with congenitally corrected transposition of the great arteries (TGA), 12 with surgically corrected TGA, and 27 with a subpulmonary pressure overloaded RV. QRS duration and dispersion were measured manually from standard ECG recorded twice within five years. RV end diastolic volume (EDV) and RV mass were determined by magnetic resonance imaging. Brain natriuretic peptide (BNP) plasma concentrations were measured. Results: QRS duration and QRS dispersion increased in all patient groups during the follow up period. QRS duration increased significantly in the congenitally corrected TGA (p = 0.04) and the subpulmonary pressure overloaded RV groups (p = 0.01). QRS dispersion increased significantly in patients with surgically corrected TGA (p = 0.03) and in the subpulmonary pressure overloaded RV group (p = 0.02). A significant correlation was found between QRS duration and RVEDV (r = 0.71, p < 0.0001). RV mass was significantly correlated with QRS duration in patients with tetralogy of Fallot (r = 0.67, p = 0.01). Mean (SD) plasma brain natriuretic peptide concentrations (6.6 (5.4) pmol/l) were increased compared with normal reference values but no correlation was found with ECG parameters or RV systolic pressure. No malignant arrhythmia or sudden death occurred. Conclusions: ECG parameters worsened gradually in asymptomatic or minimally symptomatic patients with chronic RV pressure overload, regardless of the nature of their congenital heart disease. In all patients, a significant positive correlation was found between QRS duration and RVEDV. In patients with tetralogy of Fallot there was also a correlation between QRS duration and RV mass.

[1]  E. E. van der Wall,et al.  Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction , 2001, Heart.

[2]  Geoffrey I. Webb,et al.  Impact of Pulmonary Valve Replacement on Arrhythmia Propensity Late After Repair of Tetralogy of Fallot , 2001, Circulation.

[3]  M Gutberlet,et al.  Relation between right ventricular enlargement, QRS duration, and right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation after surgical repair , 2000, Heart.

[4]  Geoffrey I. Webb,et al.  Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? , 2000, Heart.

[5]  M. Cowie.  BNP: soon to become a routine measure in the care of patients with heart failure? , 2000, Heart.

[6]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[7]  M. Kinoshita,et al.  Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. , 1999, European heart journal.

[8]  D. Barnett,et al.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. , 1999, European heart journal.

[9]  L. Daliento,et al.  Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot , 1999, Heart.

[10]  W. Parks,et al.  Three-dimensional echocardiographic measurement of right ventricular volume in children with congenital heart disease validated by magnetic resonance imaging. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[12]  D. Fassbender,et al.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: identification of the target vessel by myocardial contrast echocardiography , 1998 .

[13]  S. Kuribayashi,et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.

[14]  G. Marx,et al.  Electrocardiographic Markers of Late Sudden Death Risk in Postoperative Tetralogy of Fallot Children , 1997, Journal of cardiovascular electrophysiology.

[15]  N Hosten,et al.  Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass. , 1997, Heart.

[16]  P. Gillette,et al.  QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot. , 1997, The American journal of cardiology.

[17]  M. Gatzoulis,et al.  Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia? , 1997, Circulation.

[18]  M. Gatzoulis,et al.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. , 1995, Circulation.

[19]  C. Berul,et al.  Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. , 1994, The American journal of cardiology.

[20]  K. Bailey,et al.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction , 1993, The Lancet.

[21]  S. Cullen.  Ventricular arrhythmias in postoperative tetralogy of Fallot. , 1992, Irish medical journal.

[22]  S. Oparil,et al.  Myocardial cell hypertrophy or hyperplasia. , 1984, Hypertension.

[23]  Daniel E. Guyer,et al.  Echocardiographic measurement of right ventricular volume. , 1984, Circulation.

[24]  J. Perloff,et al.  Development and regression of increased ventricular mass. , 1982, The American journal of cardiology.

[25]  W Grossman,et al.  Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.